Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by garygpon Oct 20, 2014 1:22pm
176 Views
Post# 23043939

RE:RE:New study out using Ventripoint

RE:RE:New study out using Ventripointsr; Agree wholeheartedly with your post and I'll go one step further and add it's time for a leadership review and the ousting of George Adams. He (Adam's), brings no value at any level IMO, has diluted shareholders by a factor or 2 or more, and his 225,000 dollar annual salary plus perks for what he has provided or accomplished is laughable. You spoke of a business plan for the company....that's exactly what Adam's was tasked with 5 years ago to do, and has failed to provide. This is what current management is so desperately attempting to do now. We are behind in the market by 3 years from where we should be. It's time Adam's was shown the door, and soon. In my next post, I'll let you know what I really think. Gary.
Bullboard Posts